Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Nogo B Receptor (NUS1) (Middle Region) Peptide

NUS1 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN5673737
  • Target See all Nogo B Receptor (NUS1) products
    Nogo B Receptor (NUS1)
    Protein Region
    Middle Region
    Origin
    Human
    Source
    • 2
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Sequence
    YDHQGIFKRN NSRLMDEILK QQQELLGLDC SKYSPEFANS NDKDDQVLNC
    Characteristics
    This is a synthetic peptide designed for use in combination with anti- NUS1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Storage
    -20 °C
    Storage Comment
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    Nogo B Receptor (NUS1)
    Synonyms
    C6orf68 Peptide, MGC:7199 Peptide, NgBR Peptide, TANGO14 Peptide, 1600027K07Rik Peptide, AU019165 Peptide, AW538011 Peptide, BC003223 Peptide, D10Ertd438e Peptide, NUS1 dehydrodolichyl diphosphate synthase subunit Peptide, NUS1 Peptide, Nus1 Peptide
    Background
    This gene encodes a type I single transmembrane domain receptor, which is a subunit of cis-prenyltransferase, and serves as a specific receptor for the neural and cardiovascular regulator Nogo-B. The encoded protein is essential for dolichol synthesis and protein glycosylation. This gene is highly expressed in non-small cell lung carcinomas as well as estrogen receptor-alpha positive breast cancer cells where it promotes epithelial mesenchymal transition. This gene is associated with the poor prognosis of human hepatocellular carcinoma patients. Naturally occurring mutations in this gene cause a congenital disorder of glycosylation and are associated with epilepsy. A knockout of the orthologous gene in mice causes embryonic lethality before day 6.5. Pseudogenes of this gene have been defined on chromosomes 13 and X.

    Alias Symbols: NgBR, C6orf68, TANGO14, MGC:7199

    Protein Size: 293
    Gene ID
    116150
    NCBI Accession
    NM_138459, NP_612468
    UniProt
    Q96E22
You are here:
Support